Arkolith/Insider Trading/UNCY/Form 4

Aggarwal Gaurav

DirectorUnicycive Therapeutics, Inc. (UNCY) · full profile →Form 4 · filed Feb 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2025Conversion(C)1.4M——11.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2025Disposed to issuer(D)686$1000.00$686K3K

Transaction Codes

C
Conversion of a derivative
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-015152) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML